May 01, 2023

For more than 30 years, umbilical cord blood (UCB) has been an important stem cell source for patients with leukemia, lymphoma and MDS

April 27, 2023

Residual disease may still be present even when a patient is considered “in remission”. Lingering traces of leukemia make a transplant less effective.

April 25, 2023

The work Dr. Tinsley-Vance is doing is important and will have a big impact on the way we look at patient decision making and our support of caregivers.

February 06, 2023

Researchers find that bone marrow transplant recipients have a higher incidence of GI cancers in the years to follow.

January 30, 2023

Many factors contribute to health inequity including access to care, health insurance, cost, and education

January 25, 2023

In this interview with HealthTree, Dr. Stein shares with us research being presented at the ASH 2022 meeting that he thinks patients should be excited about.

January 19, 2023

At the ASH 2022 meeting, Dr. Pollyea discusses his research evaluting the need for a new classification system for those receiving azacitidine and venetoclax.

January 12, 2023

Dr. Becker shares with us her exciting research surrounding individualized treatments for AML patients.

January 04, 2023

Many centers tell stem cell transplant patients to restrict their diet after transplant to prevent infection. Stats say it doesn't make much difference.

December 29, 2022

Treatment with venetoclax and CLIA resulted in a high percentage of patients achieving complete remission and MRD-negative remission.